Hartmut Link

Author PubWeight™ 21.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 2013 5.72
2 Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 2012 2.97
3 September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist 2008 1.71
4 Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primary. Onkologie 2009 1.40
5 Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma". J Dtsch Dermatol Ges 2013 1.25
6 Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002 1.14
7 Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2013 0.96
8 Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis. J Leukoc Biol 2006 0.95
9 Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003 0.94
10 Activation-induced depletion of protein kinase C alpha provokes desensitization of monocytes/macrophages in sepsis. J Immunol 2005 0.88
11 S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version. J Dtsch Dermatol Ges 2013 0.88
12 Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia. Br J Haematol 2013 0.82
13 Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study. Br J Haematol 2014 0.80
14 Erythropoietins should be used according to guidelines. Lancet Oncol 2008 0.79
15 Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV. Ann Hematol 2014 0.78
16 Supportive Treatments for Patients with Cancer. Dtsch Arztebl Int 2017 0.75
17 [Hemochromatosis after chemotherapy. Is there a treatment recommendation?]. MMW Fortschr Med 2011 0.75
18 Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial. Int J Cancer 2017 0.75
19 [Diagnostic and treatment principles of iron deficiency anaemia]. MMW Fortschr Med 2015 0.75